knowledge -WSS

knowledge

author：focus 2025-10-02 01:07:38 - browse：67

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： The high cost of giving birth even with insurance
Next article： H5N1 bird flu: what we're starting to learn about infection in cows

WSS

Listen: Vivek Ramaswamy's star turn & leaky drug data

First recipient of genetically engineered pig kidney has died

Telehealth startups turn to complex chronic diseases

Vivek Ramaswamy made waves in the debate, much as in biotech

Can U.S. cancer drug shortages be fixed?

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Wikipedia

knowledge

knowledge

Cancer drug shortages should be causing more outrage

Readout LOUD podcast: What to know about H5N1 bird flu

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers on aging grapple with how to calculate biological age

Medical leaders decry Supreme Court decision on affirmative action

Health officials lay out plans to cope with respiratory virus season

After affirmative action ruling, medical educators look to 'holistic review'

Brain worms: The science behind RFK Jr.'s parasitic infection

In age of alternative facts, a scholarly course on calling out crap

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

knowledge

As obesity drug market grows, telehealth companies court payers

Sanofi strikes deal with Novavax, boosting the vaccine maker

Bird flu outbreak in cows is latest avian flu curveball

Bird flu outbreak in cows is latest avian flu curveball

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

explore

explore

hotspot

leisure time